Q2 FY26 Results: revenue up 22% in H1, but PAT and margins fall

Revenue Growth 20pctEbitda Margin CompressionNegative Operating CashflowResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.7%Reaction day

₹85.49

prior close

₹84.23

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%-4.3% vs market

Pharmaceuticals peers, median of 155sector-0.1%-4.5% vs sector

On the reaction day the stock moved 4.3 pts less than Nifty Microcap 250 and 4.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.7

10m

-3.4

15m

-2.7

30m

-2.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.7-0.4-4.3-0.1-4.5

Next day

-5.0-0.6-4.3-0.7-4.3

-4.2+0.3-4.5+0.4-4.6

-4.0+0.2-4.2+0.0-4.0

-4.8+0.1-5.0+0.4-5.2

-5.3+0.7-6.0+0.3-5.6

-5.5-0.3-5.2-0.7-4.8

15d

-6.4-2.0-4.4-1.4-5.0

-6.6-5.7-0.9-3.6-3.0

-10.1-7.8-2.3-6.2-3.9

-2.2-4.6+2.5-6.9+4.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma reported H1 FY26 revenue of Rs 372.36 cr, up 22.5% YoY. Q2 revenue rose 12% to Rs 185.88 cr. However, Q2 PAT fell to Rs 7.61 cr from Rs 15.04 cr. H1 PAT dropped 35% to Rs 15.91 cr. EBITDA margin compressed to 6.92% from 12.22% in Q2. Operating cash flow turned deeply negative at Rs 26.80 cr outflow in H1 vs Rs 1.86 cr last year. Bonus shares 1:1 allotted in July 2025. Revised governance policies adopted.

Likely market impact

Revenue growth is healthy but profit and cash generation are under pressure. Watch margin and working capital trends closely.